Initial Experience With the AngioVac Venous Drainage Cannula
- Conditions
- Heart Disease
- Registration Number
- NCT02775565
- Lead Sponsor
- Angiodynamics, Inc.
- Brief Summary
This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Consecutive patients treated at each study site between February 1, 2013 and February 28, 2015 will be included.
- Patients treated with the AngioVac venous drainage system outside of those dates.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detailing early clinical experience with the AngioVac Venous Drainage Cannula Experience and success is determined immediately after the procedure is completed. No subject follow up data is collected and retrospective data will be reviewed.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Providence St. Joseph
🇺🇸Burbank, California, United States
MUSC
🇺🇸Charleston, South Carolina, United States
UCLA
🇺🇸Los Angeles, California, United States
Sanford Research
🇺🇸Fargo, North Dakota, United States
Swedish Health Services
🇺🇸Seattle, Washington, United States